Değişik Seviyelerde Böbrek Fonksiyonu Olan Yeni Tanı Almış Hipertansif Hastalarda Paratiroid Hormon, İnsülin Direnci ve Kan Basıncı Arasındaki İlişki

1. Lima NK, Abbasi F, Lamendola C, Reaven GM: Prevalence of
insulin resistance and related risk factors for cardiovascular disease
in patients with essential hypertension. Am J Hypertens 2009; 22:
106-111
2. Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC,
Hollenberg NK, Seely EW: Insulin resistance in hypertensives:
Effect of salt sensitivity, renin status and sodium intake. J Hypertens
2001; 19: 99-105
3. Fliser D, Franek E, Fode P, Stefanski A, Schmitt CP, Lyons M, Ritz
E: Subacute infusion of physiological doses of parathyroid hormone
raises blood pressure in humans. Nephrol Dial Transplant 1997; 12:
933-938
4. Massry SG, Iseki K, Campese VM: Serum calcium, parathyroid
hormone, and blood pressure. Am J Nephrol 1986; 6: 19-28
5. Mann JFE, Wiecek A, Bommer J, Ganten U, Ritz E: Effects of
parathyroidectomy on blood pressure in spontaneously hypertensive
rats. Nephron 1987; 45: 46-52
6. Kumar S, Olukoga AO, Gordon C, Mawer EB, France M Hosker
JP, Davies M, Boulton AJ: Impaired glucose tolerance and insulin
sensitivity in primary hyperparathyroidism. Clin Endocrinol 1994;
40: 47-53
7. Ayturk S, Gursoy A, Bascil Tutuncu N, Ertugrul DT, Guvener
Demirag N: Changes in insulin Sensitivity and glucose and bone
metabolism over time in patients with asymptomatic primary
hyperparathyroidism. J Clin Endocrinol Metab 91: 4260-4263
8. Junge W, Wilke B, Halabi A, Klein G: Determination of reference
intervals for serum creatinine, creatinine excretion and creatinine
clearance with an enzymatic and a modifi ed Jaffe method. Clin
Chim Acta 2004; 344: 137-148
9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA,
Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella
EJ; Joint National Committee on Prevention, Detection, Evaluation,
and Treatment of High Blood Pressure. National Heart, Lung, and
Blood Institute; National High Blood Pressure Education Program
Coordinating Committee: Seventh Report of the Joint National
Committee on prevention, detection, evaluation, and treatment of
high blood pressure. Hypertension 2003; 42: 1206-1252
10. Reaven GM, Lithell H, Landsberg L: Hypertension and associated
metabolic abnormalities: The role of insulin resistance and the
sympathoadrenal system. N Engl J Med 1996; 334: 374-380
11. Hall JE, Brands MW, Dixon WN, Smith MJ Jr: Obesity-induced
hypertension. Renal function and systemic hemodynamics.
Hypertension 1993; 22: 292-299
12. Julius S: Corcoran Lecture. Sympathetic hyperactivity and coronary
risk in hypertension. Hypertension 1993; 21: 886-893
13. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G,
Baron AD: Obesity/insulin resistance is associated with endothelial
dysfunction. Implications for the syndrome of insulin resistance. J
Clin Invest 1996; 97: 2601-2610
14. Gennari C, Nami R, Gonnelli S: Hypertension and primary
hyperparathyroidism: The role of adrenergic and renin-angiotensinaldosterone
systems. Miner Electrolyte Metab 1995; 21: 77-8115. Schleiffer R: Parathyroid hormone and genetic hypertension. Int J
Cardiol 1992; 35: 303-310
16. Jorde R, Svartberg J, Sundsfjord J: Serum parathyroid hormone as a
predictor of increase in systolic blood pressure in men. J Hypertens
2005; 23: 1639-1644
17. Broulik PD, Horký K, Pacovský V: The effect of parathyroid
hormone on plasma renin activity in humans. Horm Metab Res
1986; 18: 490-492
18. Vlachakis ND, Frederics R, Valasquez M, Alexander N, Singer F,
Maronde RF: Sympathetic system function and vascular reactivity
in hypercalcemic patients. Hypertension 1982; 4: 452-458
19. Nilsson IL, Åberg J, Rastad J, Lind L: Endothelial vasodilatory
dysfunction in primary hyperparathyroidism is reversed after
parathyroidectomy. Surgery 1999; 126: 1049-1055
20. Hedbäck GM, Odén AS: Cardiovascular disease, hypertension and
renal function in primary hyperparathyroidism. J Intern Med 2002;
251: 476-483
21. Hulter HN, Melby JC, Peterson JC, Cooke CR: Chronic continuous
PTH infusion results in hypertension in normal subjects. J Clin
Hypertens 1986; 2: 360-370
22. Chiu KC, Chuang LM, Lee NP, Ryu JM, McGullam JL, Tsai GP,
Saad MP: Insulin sensitivity is inversely correlated with plasma
intact parathyroid hormone level. Metabolism 2000; 49: 1501-1505
23. Hjelmesaeth J, Hofsø D, Aasheim ET, Jenssen T, Moan J, Hager H,
Røislien J, Bollerslev J: Parathyroid hormone, but not vitamin D, is
associated with the metabolic syndrome in morbidly obese women
and men: A cross-sectional study. Cardiovasc Diabetol 2009; 8: 7
24. Ljunghall S, Palmér M, Akerström G, Wide L: Diabetes mellitus,
glucose tolerance and insulin response to glucose in patients with
primary hyperparathyroidism before and after parathyroidectomy.
Eur J Clin Invest 1983; 13: 373-377
25. Kautzky-Willer A, Pacini G, Niederle B, Schernthaner G, Prager R:
Insulin secretion, insulin sensitivity and hepatic insulin extraction
in primary hyperparathyroidism before and after surgery. Clin
Endocrinol (Oxf) 1992; 37: 147-55
26. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA,
Wright AD, Turner RC, Holman RR: Association of systolic blood
pressure with macrovascular and microvascular complications of
type 2 diabetes (UKPDS 36): Prospective observational study. BMJ
2000; 321: 412-419
27. Zanchetti A, Bond MG, Hennig M, Neiss A, Mancia G, Dal Palu
C, Hansson L, Magnani B, Rahn KH, Reid J, Rodicio J, Safar M,
Eckes L, Ravinetto R: Risk factors associated with alterations in
carotid intima-media thickness in hypertension: Baseline data from
the European Lacidipine Study on Atherosclerosis. J Hypertens
1998; 16: 949-961
28. Bergman RN, Prager R, Volund A, Olefsky JM: Equivalence of
the insulin sensitivity index in man derived by the minimal model
method and the euglycemic glucose clamp. J Clin Invest 1987; 79:
790-800